Introduction: Why pharma cold chain tracking matters in 2025
Keeping medicines and vaccines potent requires more than refrigerated trucks. By November 2025 temperaturecontrolled shipments accounted for roughly 23 % of pharma logistics budgets—up from 18 % in 2020. The healthcare coldchain logistics market grew from US$59.97 billion in 2024 to US$65.14 billion in 2025 and is projected to reach US$137.13 billion by 2034. As a result, you need reliable tracking systems to avoid costly temperature excursions and regulatory penalties. This guide explains how modern tracking solutions—from IoT sensors to AI analytics—help you maintain product integrity, meet evolving regulations and reduce waste. The insights are based on the latest data and trends up to November 2025.
Understand key challenges in pharma coldchain logistics tracking, such as supplychain fragility, rising costs and talent shortages.

Learn how IoT sensors, blockchain and AI enable realtime visibility, predictive analytics and endtoend traceability.
Navigate regulatory requirements like the U.S. DSCSA, EU Falsified Medicines Directive and WHO Good Distribution Practice.
Incorporate sustainability and packaging innovations to cut emissions and preserve product quality.
Explore 2025 market trends and technologies including AIdriven route optimisation, quantum computing and portable cryogenic freezers.
What challenges plague pharma coldchain logistics tracking in 2025?
Rising costs and supplychain fragility. In 2025, 63 % of pharmaceutical manufacturers report rawmaterial prices rising by more than 22 % since 2022. Nearly 58 % of activeingredient suppliers are concentrated in three Asian countries, creating singlepointfailure risks when climate events or geopolitical tensions disrupt sourcing. These disruptions contribute to a 12 % product recall rate and US$35 billion in annual losses from temperature excursions.
Talent shortages. About 40 % of organisations face critical shortages of digital logistics and advancedtherapy production staff. Without skilled personnel, deploying new tracking technologies becomes difficult.
Temperature diversity. Different drug classes require unique storage windows: vaccines and insulin need 2–8 °C, biologics often require freezing below –20 °C, while cell and gene therapies demand –80 °C to –150 °C. Managing multiple temperature bands across complex routes increases the risk of excursions.
How temperature ranges impact logistics
Temperature control isn’t onesizefitsall. The table below summarises common ranges, example therapies and practical implications for you.
| Temperature range | Example products | Typical shipping modes | What it means for you |
| 2–8 °C (Refrigerated) | Standard vaccines, insulin, GLP1 agonists (demand grew 300 % since 2023) | Refrigerated trucks, insulated coolers | Requires reliable shortterm storage; failure leads to potency loss and recalls |
| Below –20 °C (Frozen) | Many biologics and specialty drugs | Powerredundant freezers, passive containers with phasechange materials | Packaging must maintain the range for 120+ hours, increasing logistical complexity |
| –80 °C to –150 °C (Cryogenic) | CART cell therapies, mRNA vaccines | Liquidnitrogen dewars, dryice shippers | Demands specialised containers and rapid transport; small fluctuations can destroy milliondollar batches |
| 15–25 °C (Controlled room temp) | Many tablets, diagnostic reagents | Insulated cartons, standard containers | Often overlooked; ambient shipments still require monitoring because heat waves or cold snaps can push them outside specification |
Practical tips and advice
Map your thermal profile: Document temperature limits for each product; this guides packaging choices and route planning.
Choose validated containers: Vacuuminsulated panels and phasechange materials can protect shipments for over 120 hours.
Plan for emergencies: Develop procedures covering delays, route changes and power failures; include instructions for adding dry ice or transferring products when sensors show drift.
Invest in training: Human error is a major contributor to deviations; ensure drivers, warehouse staff and technicians know how to handle products and respond to alerts.
Partner with experts: Experienced thirdparty logistics providers offer infrastructure and expertise to maintain the cold chain.
Case study: During the pandemic, a biotech firm shipping CART therapies used AIoptimised routing and realtime IoT sensors. When a blizzard threatened delivery, the system rerouted the truck and alerted a backup driver. The therapy arrived within its 72hour viability window, preventing a multimilliondollar loss.
How do IoT sensors and blockchain enable realtime visibility?
Traditional coldchain monitoring relied on data loggers and periodic manual checks, revealing problems only after a shipment arrived. Today, IoT (Internet of Things) devices collect continuous temperature, humidity, shock and location data, streaming it to cloud platforms. This shift provides early warning of excursions and deep visibility across the supply chain.
Core components of IoTenabled monitoring
Embedded sensor networks: Wireless sensors placed in packages, pallets or containers measure temperature, humidity, light exposure and GPS coordinates. For example, modern sensors deliver data every 15 seconds with ±0.1 °C precision.
Cloudbased platforms: Sensor data flows into secure cloud dashboards, creating GDPcompliant archives and realtime visibility for manufacturers, logistics teams and regulators.
Predictive analytics: AI and machinelearning models analyse environmental trends to forecast risks, detect equipment failures and issue early alerts.
Automated documentation: IoT platforms automatically record temperature history and location data, aligning with FDA 21 CFR Part 11 and EU GDP requirements.
Blockchain for traceability: Distributed ledger technology records each handoff and temperature reading, providing an immutable and transparent record. Merck’s pilot with the U.S. FDA uses blockchain to track medicines from manufacturer to patient, combating a US$4.5 billion counterfeit market.
Benefits for you
| Technology | Main features | Practical significance |
| IoT sensors & GPS | Provide realtime data at 15second intervals with ±0.1 °C precision; integrated GPS for location | Enables constant monitoring, triggers alerts before excursions and reduces anxiety for patients and shippers |
| Blockchain | Records every transaction on a tamperproof ledger | Prevents counterfeiting, simplifies audits and improves supplychain transparency |
| Predictive analytics | Forecasts demand, predicts disruptions and reduces waste by 28 % | Optimises inventory, reduces urgent shipments and ensures timely deliveries |
| Autonomous units & drones | Selfdriving freezers handle 30 % of metropolitan deliveries; drones serve remote areas | Expands reach, lowers labour costs and shortens delivery times |
| Quantum computing & digital twins | Optimises 22 000node networks in minutes; simulates entire chains without physical risk | Helps design resilient routes and test compliance scenarios |
Tips for leveraging IoT and blockchain
Audit your routes: Use AI tools to map every handoff point, combining traffic and weather data to choose the fastest paths.
Invest in sensors & predictive analytics: Realtime data reduces waste and predictive shelflife modelling helps prioritise shipments when supply is tight.
Embrace automation: Hyperautomated warehouses and AIpowered robots reduce errors and free staff for highvalue tasks.
Explore blockchain solutions: Recording every temperature reading on a distributed ledger improves traceability and may satisfy regulatory audits.
Address cybersecurity: Connected devices introduce datasecurity risks—ensure proper encryption and regular vulnerability assessments.
Realworld example: During the COVID19 vaccine rollout, Pfizer used IoTequipped containers with automated dryice replenishment to maintain −70 °C conditions across thousands of miles.
How do AI and predictive analytics optimise coldchain logistics?
AI and machinelearning algorithms turn the flood of sensor data into actionable insights. They optimise routes, anticipate disruptions and improve shelflife predictions.
Route optimisation and risk mitigation
AIpowered route planning: By analysing realtime traffic and weather data, AI can generate optimised shipping routes, ensuring temperaturesensitive deliveries arrive promptly. This reduces transit time and the risk of quality degradation.
Predictive alerts: Combining predictive analytics with AIpowered IoT devices helps identify upcoming temperature excursions and triggers immediate alerts. For example, the system might reroute a refrigerated truck or instruct staff to add dry ice.
Demand forecasting: AI models forecast demand and anticipate disruptions. Eli Lilly uses predictive analytics to optimise inventory and reduce waste. Such models consider epidemiological trends, seasonality and consumption patterns to align production and distribution.
Machine learning for continuous improvement: Algorithms continually learn from historical and realtime data to refine routes, reduce energy consumption and identify inefficiencies.
AIpowered computer vision: Some systems include cameras that inspect shipments for damage or leakage, enabling early intervention.
Digital twins and quantum computing
Digital twins create virtual replicas of entire coldchain networks. Using quantum algorithms, planners can optimise thousands of nodes within minutes and test scenarios without risking real shipments. This helps design resilient systems that withstand natural disasters, geopolitical shocks or pandemics.
Practical tips for AI adoption
Start small: Pilot AI routeoptimisation tools on highrisk lanes before scaling across the network.
Integrate data sources: Consolidate IoT sensor data, carrier milestones and supplychain events into a single platform to train models effectively.
Automate decision workflows: Automating timeoutofrange and productrelease decisions can save quality teams time, although human oversight remains essential.
Use predictive shelflife modelling: AI can prioritise shipments based on remaining shelf life, reducing waste by up to 28 %.
Explore quantum optimisation: If you manage large networks, consider emerging quantumcomputing tools for route planning and resource allocation.
Why is regulatory compliance critical in 2025?
Regulatory bodies have tightened traceability and safety requirements. Noncompliance leads to fines, product destruction and loss of patient trust. In 2025, several deadlines and guidelines are converging:
Key frameworks and deadlines
| Regulation | Scope | 2025 deadline & requirements | What it means for you |
| U.S. Drug Supply Chain Security Act (DSCSA) | Electronic tracking of prescription drugs at package level | Manufacturers & repackagers: 27 May 2025; wholesalers: 27 August 2025; large dispensers: 27 November 2025 | Implement interoperable tracking systems, assign serial numbers to each package and ensure realtime data exchange |
| EU Falsified Medicines Directive (FMD) | Anticounterfeiting for EU prescriptions | Requires unique identifiers and tamperevident devices on all prescription medicines | Adopt tamperevident packaging and scanning systems; pharmacies must verify medicines before dispensing |
| WHO Good Distribution Practices (GDP) | Controlledroomtemperature (CRT) products | Updated guidance emphasises robust temperature mapping and continuous monitoring for 15–25 °C products | Review CRT protocols and implement continuous monitoring even for ambient shipments |
| ICH Q12 & Q13 | Harmonised postapproval changes and distribution practices | Unified global standards for change management and GDP | Align quality systems with global expectations and streamline regulatory submissions |
| Biosecure Act (U.S.) | Limits partnerships with certain foreign biotech firms | May restrict federally funded companies from working with designated “biotechnology companies of concern” | Diversify supplier base and monitor legislative developments |
Compliance best practices
Maintain complete chain of custody: Record every handoff digitally to produce transaction histories on demand.
Validate packaging and routes: Perform risk assessments and validation studies to ensure packaging can withstand worstcase scenarios.
Train staff and conduct audits: Regular training and internal audits ensure adherence to GDP and DSCSA requirements.
Prepare for DSCSA audits: Implement systems capable of generating electronic transaction information, history and statements whenever regulators request them.
Stay informed: Subscribe to updates from the FDA, EMA and WHO. Keep an eye on emerging legislation like the Biosecure Act and evolving global guidelines.
Tip: Noncompliance can lead to product destruction and consignment delays. Dedicate resources to understanding global regulations and partner with experts who have deep knowledge of customs codes and labelling requirements.
How is sustainability reshaping pharma coldchain tracking?
Sustainability has moved from a nicetohave to a regulatory and consumer expectation. The EU Green Pharma Pact calls for a 45 % reduction in coldchain emissions by 2028. Sustainable practices also save money by reducing energy consumption and waste.
Renewable energy and storage innovations
Solarpowered cold storage: Rural sites are adopting solar units that deliver electricity for 3.2–15.5 cents per kWh, compared with typical utility rates of 13.1 cents per kWh. Solar power keeps medicines safe in regions with unreliable grids and reduces operational costs.
Ammoniabased refrigeration: Some companies are experimenting with natural refrigerants like ammonia to replace highglobalwarming hydrofluorocarbons.
Electrified fleets and optimised routes: Companies are shifting to electric or hybrid trucks and using AI to reduce fuel consumption and emissions.
Sustainable packaging
Reusable and biodegradable materials: Recyclable insulated containers, biodegradable wraps and reusable cold packs minimise waste. However, Biocair warns that thermal performance must be maintained across routes and seasons.
Phasechange materials (PCMs): Vacuuminsulated panels combined with PCMs can keep shipments within temperature ranges for over 120 hours.
4Dprinted smart packaging: Emerging innovations use shapememory polymers that change shape to regulate temperature; this helps maintain product integrity in dynamic conditions.
Circular economy and collaboration
Reuse and recycling: Companies such as Johnson & Johnson are adopting circular practices by reusing blister packs and vials.
Collaboration across the supply chain: Sustainability goals require partnerships among manufacturers, logistics providers and regulators. Biocair notes that collaboration enables companies to unlock new resources and navigate postBrexit complexities.
Carbon tracking dashboards: Use tools to measure your carbon footprint and identify where to reduce emissions.
Optimise fleet utilisation: Combine shipments to reduce empty miles and coordinate returns to reuse packaging.
Example: A distributor switched to optimised routing and reusable containers for insulin shipments. As a result, repeat deliveries dropped by 10 % and CO₂ emissions fell by 20 %.
What are the latest trends and market outlook for 2025?
The coldchain industry is evolving rapidly. Understanding current trends helps you plan investments and stay competitive.
Market growth and regional dynamics
Market size: The global healthcare coldchain logistics market was valued at US$59.97 billion in 2024 and grew to US$65.14 billion in 2025, with a projected CAGR of 8.63 % from 2025 to 2034.
Cryogenic logistics: Ultralowtemperature shipments (–80 °C to –150 °C) account for 31.45 % of the coldchain market.
Regional leaders: North America holds 42.87 % of the global market, driven by high demand for biologics and robust infrastructure. AsiaPacific is the fastestgrowing region due to increasing vaccine manufacturing and investment.
Driving segments: Biopharmaceuticals generated the largest revenue in 2024, while vaccines are expected to see the fastest growth. The storage segment accounted for the largest revenue, with transportation growing fastest.
Technology and innovation trends
Digital transformation: AIdriven analytics, IoT and smart packaging enable predictive demand forecasting and dynamic routing. Shared visibility across manufacturers, logistics providers and healthcare professionals improves decisionmaking.
Advanced planning & risk management: AI models assess epidemiological trends and seasonality to predict future demand and optimise resource allocation.
Autonomous delivery: Selfdriving freezers deliver 30 % of metropolitan shipments and drones operate in 12 countries, extending reach to remote areas.
Quantum optimisation & digital twins: Optimise large networks and simulate entire cold chains, reducing risk without disrupting operations.
Smart cryogenic containers: IoTenabled cryogenic containers actively manage –150 °C shipments and provide realtime tracking.
4D printed packaging: Uses shapememory materials to selfregulate temperature.
Hyperpersonalised logistics: Patientspecific temperature profiles and 3D printed biologics may eventually reduce coldchain requirements.
Emerging regional innovations
Southeast Asia is becoming a hub for coldchain innovation. Examples include blockchainbased traceability systems, solarpowered cold storage, IoTenabled sensors and AIpowered route optimisation. Portable cryogenic freezers maintain –80 °C to –150 °C temperatures even in remote areas. These innovations demonstrate that emerging markets are leading in sustainable and techdriven solutions.
How do you implement an effective pharma coldchain tracking program?
Ensuring your coldchain programme meets 2025 standards requires strategic planning, technology integration and continuous improvement.
Stepbystep approach
Assess risks and map the chain: Identify all nodes—from manufacturing to lastmile delivery—and note potential vulnerabilities (equipment failures, handling errors, transit delays).
Select the right technology: Choose IoT sensors with appropriate precision and battery life; ensure platforms support realtime alerts, predictive analytics and blockchain integration. Consider whether AI and machinelearning models will be built inhouse or via a vendor.
Validate packaging and transportation: Conduct temperaturemapping studies and stress tests to confirm that packaging maintains required ranges across various ambient conditions.
Establish SOPs and digitise documentation: Create standard operating procedures for packaging, handling and responding to alerts. Digitise SOPs and risk assessments; this unlocks value when combined with contextualised data and automated workflows.
Train personnel: Provide continuous training on handling temperaturesensitive products, using monitoring devices and responding to alerts.
Integrate with supplychain partners: Build datasharing partnerships with carriers, 3PLs and healthcare providers. Use dataagnostic control towers that overlay passive and active IoT data, carrier milestones and ELD data in one view.
Monitor and optimise: Use AI and predictive analytics to monitor performance, identify deviations between planned lanes and actual performance, and generate rootcause analyses and recommendations.
Plan for sustainability: Evaluate carbon footprint, adopt renewable energy where possible and implement reusable packaging. Engage suppliers and partners to collaborate on emissions reduction.
Prepare for audits: Keep electronic transaction histories, quality records and serialisation data ready for regulators. Implement systems capable of producing transaction information and statements on demand.
Decision tool: Are you coldchain ready?
Ask yourself the following questions:
Do you have continuous visibility? If not, consider deploying IoT sensors and cloud platforms for realtime monitoring.
Are your SOPs digitised? Manual paperwork hampers efficiency; digitising SOPs enables automation and datadriven risk analysis.
Is your supply chain sustainable? Evaluate energy usage, packaging waste and carbon emissions; adopt solar power and reusable materials where feasible.
Can you prove compliance? Ensure your system can generate required transaction histories and audit trails for DSCSA, FMD and WHO guidelines.
Do you use predictive analytics? If you’re still reacting to alarms rather than anticipating excursions, integrate AI models to forecast risks.
Latest developments and trends in 2025
As of November 2025, several advancements are shaping pharma coldchain tracking:
Predictive shelflife AI: Reduces waste by 28 % by forecasting product expiry and prioritising shipments.
Autonomous mobile freezers: Handle 30 % of metropolitan deliveries, reducing humanresource constraints.
Quantum optimisation: Solves network route problems across 22 000 nodes in under five minutes.
4Dprinted smart packaging: Uses shapememory polymers that adapt to temperature changes, enhancing product protection.
IoTenabled cryogenic containers: Maintain –150 °C shipments with realtime tracking, vital for cell and gene therapies.
Generative AI & digital twins: Tools like generative AI automate documentation and integrate with controltower platforms to accelerate lane qualification and risk assessments.
Market insights
Biologics surge: Biologics now account for around 30 % of all drugs, driving coldchain investment.
Cryogenic dominance: Ultracold logistics remains a fastgrowing segment; portable cryogenic freezers enable remote deliveries.
Datacentric control towers: Pharma companies demand control towers that consolidate passive, active, carrier and ELD data into a single view and provide domainspecific expertise around GxP, temperature and traceability.
Alert noise reduction: Advanced algorithms contextualise risk and silence irrelevant alerts, enabling companies to reduce monitoring service levels and costs.
Focus on planning: The real value of visibility lies in planning optimisation rather than just monitoring; organisations save more by optimising routes, packaging and inventory than by simply reducing temperature excursions.
Frequently Asked Questions
Q1: What is the 2–8 °C range, and why is it critical?
The 2–8 °C range is the optimal temperature window for storing and transporting vaccines, insulin and many biologics. Staying within this range preserves potency and prevents recalls or patient harm.
Q2: How do IoT sensors improve coldchain logistics?
IoT sensors continuously monitor temperature, humidity and location, sending realtime alerts when deviations occur. This allows you to intervene immediately, preventing spoilage and ensuring compliance.
Q3: Why is blockchain useful in pharmaceutical logistics?
Blockchain creates an immutable record of every handoff and temperature reading. It prevents data tampering, simplifies audits and helps fight the US$4.5 billion counterfeit market.
Q4: What are the main regulatory deadlines in 2025?
Under the U.S. DSCSA, manufacturers and repackagers must implement interoperable tracking by 27 May 2025, wholesalers by 27 August 2025 and large dispensers by 27 November 2025. The EU FMD requires tamperevident packaging and serialisation on all prescription medicines.
Q5: How can I reduce my coldchain carbon footprint?
Adopt solarpowered storage units, electrify your fleet, use reusable packaging and optimise routes. Solar units operate at 3.2–15.5 cents per kWh, cheaper than typical utility rates of 13.1 cents per kWh.
Summary and recommendations
By 2025, pharma coldchain logistics tracking has become a complex yet essential function. Rising costs, supplychain fragility and diverse temperature requirements demand robust monitoring and strategic planning. Modern IoT sensors, blockchain, AI and digital twins offer realtime visibility, predictive analytics and endtoend traceability, reducing waste by up to 28 %. Regulatory compliance is nonnegotiable—deadlines under DSCSA, FMD and WHO guidelines require interoperable tracking systems and rigorous documentation. Sustainability initiatives, such as solarpowered storage and reusable packaging, reduce emissions while improving efficiency. Finally, market trends show rapid growth in cryogenic logistics, autonomous delivery and AIdriven planning, positioning the cold chain for continued innovation.
Recommended next steps
Evaluate your current coldchain readiness using the decision tool above and identify gaps in visibility, compliance and sustainability.
Partner with technology providers who offer IoT sensors, blockchain integration and AI analytics tailored to pharmaceutical requirements.
Implement a dataagnostic control tower to consolidate information from passive devices, active sensors and carrier milestones.
Develop a sustainability roadmap that includes renewable energy adoption, reusable packaging and carbon tracking dashboards.
Stay abreast of regulatory changes and allocate resources for training, audits and documentation to meet DSCSA and FMD deadlines.
About Tempk
Tempk is a leading provider of temperaturecontrolled packaging and logistics solutions. We specialise in ecofriendly insulated containers, phasechange materials and reusable cold packs designed for pharmaceutical and lifescience applications. Our products help maintain strict temperature ranges for over 120 hours and are designed to meet Good Distribution Practice (GDP) standards. We partner with clients to map thermal profiles, validate routes and implement IoTenabled monitoring, ensuring compliance with DSCSA and EU FMD requirements.
Call to action
Need help improving your coldchain logistics tracking? Contact the Tempk team for customised packaging solutions, IoT sensor integration and expert guidance on regulatory compliance.